Triacetoxyperiodinane → Tert-butyl 3-acetamido-4-oxopyrrolidine-1-carboxylate
Reaction equation
[C:1]([NH:4][CH:5]1[CH:9]([OH:10])[CH2:8][N:7]([C:11]([O:13][C:14]([CH3:17])([CH3:16])[CH3:15])=[O:12])[CH2:6]1)(=[O:3])[CH3:2].CC(OI1(OC(C)=O)(OC(C)=O)OC(=O)C2C1=CC=CC=2)=O>ClCCl>[C:1]([NH:4][CH:5]1[C:9](=[O:10])[CH2:8][N:7]([C:11]([O:13][C:14]([CH3:17])([CH3:16])[CH3:15])=[O:12])[CH2:6]1)(=[O:3])[CH3:2]Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
A solution of tert-butyl 3-(acetylamino)-4-hydroxypyrrolidine-1-carboxylate obtained in Step A (680 mg) in dichloromethane (8 mL) was treated with 1,1,1-tris(acetyloxy)-1,1-dihydro-1,2-benziodoxol-3-(1H)-one (1.77 g) and stirred overnight at room temperature. The solution was then evaporated and purified on a Biotage Horizon® system (silica, gradient 50-90% ethyl acetate in hexane) to yield the title compound. LC-MS 243.2 (M+1).
Workup
- customThe solution was then evaporated
- custompurified on a Biotage Horizon® system (silica, gradient 50-90% ethyl acetate in hexane)
Sources & evidence
- ORD record
- ord-324fac426baf4d73960bc895d40575ce
- Source dataset
- uspto-grants-2010_07
- Patent number
- US07750034B2
Reaction notes
Loading…